Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cell-based microarrays: current progress, future prospects.

Ella Palmer1, Tom Freeman

  • 1MRC Rosalind Franklin Centre for Genomics Research (RFCGR), Wellcome Trust Genome Campus, Hinxton, Cambridge. CB10 1SB, UK.

Pharmacogenomics
|July 15, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bacterial defense systems and host ecology drive the evolution of intra-species lineages.

Cell reports·2026
Same author

Canadian family physician Medecin de famille canadien·2025
Same author

Revisiting Ian McWhinney's principles in the digital health age.

Canadian family physician Medecin de famille canadien·2025
Same author

Canada's THC unit: Applications for the legal cannabis market.

The International journal on drug policy·2024
Same author

A phase III multisite randomised controlled trial to compare the efficacy of cannabidiol to placebo in the treatment of cannabis use disorder: the CBD-CUD study protocol.

BMC psychiatry·2024
Same author

Understanding data provenance when using electronic medical records for research: Lessons learned from the Deliver Primary Healthcare Information (DELPHI) database.

International journal of population data science·2024
Same journal

Closely similar tacrolimus morning troughs and graft function across the recipients' common <i>ABCB1</i> polymorphisms (<i>c.2677G>T/A</i>, <i>c.1236C>T</i>, <i>c.3435C>T</i>) early after renal transplantation.

Pharmacogenomics·2026
Same journal

Pharmacogenomics for stratified antidepressant treatment in major depressive disorder: evidence, limits and a roadmap for clinical use.

Pharmacogenomics·2026
Same journal

Guidance from an informed public on collecting and sharing PGx test results for major depressive disorder: "It's no different from your blood type".

Pharmacogenomics·2026
Same journal

Optimizing pharmacogenomics workflows: a qualitative evaluation of clinical service delivery models.

Pharmacogenomics·2026
Same journal

Combinations of single gene predictors with AI-driven polygenic precision therapies in cardiovascular diseases.

Pharmacogenomics·2026
Same journal

Practical guide to implementing pre-emptive pharmacogenetic screening in routine pediatric oncology care.

Pharmacogenomics·2026
See all related articles

Cell-based microarrays enable high-throughput screening of gene function by using reverse transfection. This technology is crucial for discovering new therapeutic agents and advancing biological research.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Genomics

Background:

  • Cell-based microarrays offer a novel approach for high-throughput screening.
  • The technique was first described in 2001 for gene function analysis.

Purpose of the Study:

  • To explore the utility of cell-based microarrays for gene function screening.
  • To demonstrate the potential of this method for identifying therapeutic agents.

Main Methods:

  • Printing expression vectors of human genes onto glass slides.
  • Utilizing reverse transfection of cells on the microarray surface.
  • Employing secondary assays to detect alterations in cell function.

Main Results:

  • Demonstrated successful reverse transfection and subsequent cell function analysis.

Related Experiment Videos

  • Showcased adaptability for short interfering RNAs and compound screening.
  • Validated the potential for high-throughput screening applications.

    • Conclusions:

    • Cell-based microarrays are a powerful tool for gene function studies.
    • This technology holds significant promise for drug discovery and therapeutic agent identification.
    • Ongoing efforts focus on optimizing this platform for enhanced screening capabilities.